Enveric Share Price

Enveric Share Price

NASDAQ: ENVB | Healthcare
$0.00
-$1.41 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Enveric Stock Performance

Open
N/A
Prev. Close
$1.41
Circuit Range
N/A
Day Range
N/A
Year Range
$1.21 - $13.17
Volume
N/A
Average Traded
N/A

Enveric Share Price Chart

Line chart of the Enveric price trend over the selected period. The price fell overall, ranging from 1.41 to 1.43, ending at 1.41.
$0.00$0.00
L
Show Current Price
H

Enveric Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.51
Revenue (TTM)
$0.00
Return On Equity (TTM)
-196.45%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
36.88%

Enveric Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.04-$1.63-$3.03-$2.55
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A59.65%-85.89%15.84%

Enveric Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.80-$17.46-$9.57-$12.13
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A7.13%45.19%-26.75%

Enveric Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.160.350.721.12
Current Assets4.942.733.5818.43
Total Assets5.13.084.319.55
Non Current Liabilities0.00.00.00.0
Current Liabilities0.921.492.344.0
Total Liabilities0.921.492.344.0
Shareholders' Equity4.181.591.9614.67

Enveric Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-8.14-7.73-14.09-17.15
Investing0.00.00.01-0.58
Financing10.587.67-1.3418.18

Corporate Actions

Split
Ex-date: 28 Oct 2025

Split
Ex-date: 29 Jan 2025

Split
Ex-date: 15 Jul 2022

Split
Ex-date: 25 Nov 2019

About Enveric

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Enveric Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.52
$1.41
+3.31%
Oct 2026
$1.44
$1.36
-7.80%
Sep 2026
$1.41
$1.48
+7.66%
Aug 2026
$1.57
$1.37
-11.61%
Jul 2026
$1.46
$1.55
+12.32%
Jun 2026
$2.29
$1.38
-39.74%
May 2026
$3.83
$2.29
-41.13%
Apr 2026
$2.02
$3.89
+94.50%
Mar 2026
$2.25
$2.00
-14.71%
Feb 2026
$2.74
$2.35
-19.42%
Jan 2026
$3.94
$2.91
-23.82%
Dec 2025
$6.02
$3.82
-34.48%

Enveric Share Price FAQs